Real-world sex differences in type 2 diabetes patients treated with GLP-1 receptor agonists
Sara Piccini, Giuseppe Favacchio, Emanuela Morenghi, Gherardo Mazziotti, Andrea Lania, Marco Mirani
Topics & Concepts
MedicineGlucagon-like peptide 1 receptorType 2 diabetesGlucagon-like peptide-1Internal medicineDiabetes mellitusReceptorEndocrinologyAgonistDiabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular Health